Invivyd Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Invivyd, Inc., a Nasdaq-listed biopharmaceutical company, announced inducement grants of stock options totaling 1,083,750 shares to 16 newly hired non-executive employees. These grants conform to Nasdaq Listing Rule 5635(c)(4) and the company's 2026 Inducement Plan, with options priced at $1.33 per share, vesting over four years, and a 10-year term…